Nobleaid Pain Reliever Tablet, Delayed Release
Product Images NDC 81533-600

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 1 technical images submitted to the FDA as part of the official labeling for Nobleaid Pain Reliever (NDC 81533-600). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Noble Otc Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Image Description (81533600 1)

Image Description (81533600 1)
This text includes drug facts and warnings for a pain reliever containing Aspirin. The warning advises against use in children and teenagers with chickenpox or flu-like symptoms, and those experiencing changes in behavior, nausea, and vomiting, which could indicate Reye's syndrome. The allergy alert warns of severe allergic reactions that could cause hives, facial swelling, wheezing, or shock. The stomach bleeding warning highlights a higher risk with age, previous stomach ulcers, blood thinning or steroid drugs, and concomitant use of drugs containing prescription or non-prescription NSAIDs or alcohol. The labeling advises not using if allergic to aspirin or if pregnant or breastfeeding, and to ask a doctor before use if there is a history of stomach problems, high blood pressure, heart disease, liver cirrhosis, kidney problems, or breathing problems. The package contains 300 enteric-coated tablets.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.